β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials
Xavier Rosselló(University College London), John Munkhaugen(University of Oslo), Therese Lucia Friis Holmager(Frederiksberg Hospital), Morten Wang Fagerland(Oslo University Hospital), Alberto Domínguez‐Rodríguez(Hospital Universitario de Canarias), Pedro L. Sánchez(Instituto de Investigación Biomédica de Salamanca), Takeshi Kimura(Municipal Hirakata City Hospital), Anna Meta Dyrvig Kristensen(Frederiksberg Hospital), Stuart Pocock(University of London), Borja Ibáñez, Roberto Latini(Mario Negri Institute for Pharmacological Research), Sergio Raposeiras‐Roubín(University Hospital Complex Of Vigo), Filippo Ottani(Ospedale Infermi di Rimini), Sigrun Halvorsen, Valentı́n Fuster(Spanish National Centre for Cardiovascular Research), Dan Atar, Jess Lambrechtsen(Odense University Hospital), Neiko Ozasa(Kyoto University Hospital), Eva Prescott(Frederiksberg Hospital), Arnhild Bakken(Oslo University Hospital), Manuel Anguita(Instituto Maimónides de Investigación Biomédica de Córdoba), Svend Eggert Jensen(Aalborg University Hospital)
Cited by 63
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k